170 related articles for article (PubMed ID: 38203692)
21. The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9.
Wang X; Yang B; She Y; Ye Y
J Cell Biochem; 2018 Sep; 119(9):7790-7799. PubMed ID: 29904939
[TBL] [Abstract][Full Text] [Related]
22. Identification of MICALL2 as a Novel Prognostic Biomarker Correlating with Inflammation and T Cell Exhaustion of Kidney Renal Clear Cell Carcinoma.
Lin W; Chen W; Zhong J; Ueki H; Xu A; Watanabe M; Araki M; Liu C; Nasu Y; Huang P
J Cancer; 2022; 13(4):1214-1228. PubMed ID: 35281853
[No Abstract] [Full Text] [Related]
23. Ivermectin Augments the In Vitro and In Vivo Efficacy of Cisplatin in Epithelial Ovarian Cancer by Suppressing Akt/mTOR Signaling.
Zhang X; Qin T; Zhu Z; Hong F; Xu Y; Zhang X; Xu X; Ma A
Am J Med Sci; 2020 Feb; 359(2):123-129. PubMed ID: 32039764
[TBL] [Abstract][Full Text] [Related]
24. Dual PI3K/mTOR inhibitor PKI-402 suppresses the growth of ovarian cancer cells by degradation of Mcl-1 through autophagy.
Hu X; Xia M; Wang J; Yu H; Chai J; Zhang Z; Sun Y; Su J; Sun L
Biomed Pharmacother; 2020 Sep; 129():110397. PubMed ID: 32585451
[TBL] [Abstract][Full Text] [Related]
25. Exon 4 deletion variant of epidermal growth factor receptor enhances invasiveness and cisplatin resistance in epithelial ovarian cancer.
Zhang P; Zhang P; Zhou M; Jiang H; Zhang H; Shi B; Pan X; Gao H; Sun H; Li Z
Carcinogenesis; 2013 Nov; 34(11):2639-46. PubMed ID: 23764753
[TBL] [Abstract][Full Text] [Related]
26. Cucurbitacin E inhibits esophageal carcinoma cell proliferation, migration, and invasion by suppressing Rac1 expression through PI3K/AKT/mTOR pathway.
Zhang L; Liang H; Xin Y
Anticancer Drugs; 2020 Sep; 31(8):847-855. PubMed ID: 32568828
[TBL] [Abstract][Full Text] [Related]
27. Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.
Chuang TC; Hsu SC; Cheng YT; Shao WS; Wu K; Fang GS; Ou CC; Wang V
Cancer Lett; 2011 Dec; 311(1):11-9. PubMed ID: 21757288
[TBL] [Abstract][Full Text] [Related]
28. Dual down-regulation of EGFR and ErbB2 by berberine contributes to suppression of migration and invasion of human ovarian cancer cells.
Chuang TC; Wu K; Lin YY; Kuo HP; Kao MC; Wang V; Hsu SC; Lee SL
Environ Toxicol; 2021 May; 36(5):737-747. PubMed ID: 33325633
[TBL] [Abstract][Full Text] [Related]
29. CADM1 inhibits ovarian cancer cell proliferation and migration by potentially regulating the PI3K/Akt/mTOR pathway.
Si X; Xu F; Xu F; Wei M; Ge Y; Chenge S
Biomed Pharmacother; 2020 Mar; 123():109717. PubMed ID: 31865146
[TBL] [Abstract][Full Text] [Related]
30. USP18 contributes to the proliferation and migration of ovarian cancer cells by regulating the AKT/mTOR signaling pathway.
Liu M; Gao S; Xu X; Zhang L; Xu B; Lu D
Acta Biochim Pol; 2022 Jun; 69(2):417-422. PubMed ID: 35696596
[TBL] [Abstract][Full Text] [Related]
31. A Fra-1-dependent, matrix metalloproteinase driven EGFR activation promotes human lung epithelial cell motility and invasion.
Adiseshaiah P; Vaz M; Machireddy N; Kalvakolanu DV; Reddy SP
J Cell Physiol; 2008 Aug; 216(2):405-12. PubMed ID: 18288638
[TBL] [Abstract][Full Text] [Related]
32. Autophagy-related gene PXN as a prognostic marker: Promotion of ovarian cancer progression by suppressing the p110β/Vps34/Beclin1 pathway.
Wu Q; Cui Z; Jiang S; Xia H; Liu L; You Y; Sun Y
Cell Biochem Funct; 2023 Jul; 41(5):599-608. PubMed ID: 37232085
[TBL] [Abstract][Full Text] [Related]
33. ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3.
Ghosh S; Basu M; Roy SS
J Biol Chem; 2012 Apr; 287(18):15001-15. PubMed ID: 22270366
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo.
Guo F; Tian J; Cui M; Fang M; Yang L
Mol Med Rep; 2015 Jul; 12(1):753-9. PubMed ID: 25738807
[TBL] [Abstract][Full Text] [Related]
35. EFEMP2 upregulates PD-L1 expression via EGFR/ERK1/2/c-Jun signaling to promote the invasion of ovarian cancer cells.
Shen X; Jin X; Fang S; Chen J
Cell Mol Biol Lett; 2023 Jul; 28(1):53. PubMed ID: 37420173
[TBL] [Abstract][Full Text] [Related]
36. Micall2 Is Responsible for the Malignancy of Clear Cell Renal Cell Carcinoma.
Zeng X; Wang H; Yang J; Hu J
Yonago Acta Med; 2023 Feb; 66(1):171-179. PubMed ID: 36811029
[TBL] [Abstract][Full Text] [Related]
37. NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer.
Ren M; Zhao H; Gao Y; Chen Q; Zhao X; Yue W
J Ovarian Res; 2023 Jan; 16(1):17. PubMed ID: 36670423
[TBL] [Abstract][Full Text] [Related]
38. Effects of MFG-E8 expression on the biological characteristics of ovarian cancer cells via the AKT/mTOR/S6K signalling pathway.
Li N; Wang Y; Liu L; Wang P; Wu X
J Obstet Gynaecol; 2023 Dec; 43(1):2151354. PubMed ID: 36484512
[TBL] [Abstract][Full Text] [Related]
39. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.
Ding YH; Zhou ZW; Ha CF; Zhang XY; Pan ST; He ZX; Edelman JL; Wang D; Yang YX; Zhang X; Duan W; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():425-64. PubMed ID: 25624750
[TBL] [Abstract][Full Text] [Related]
40. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
Li Y; Wu T; Wang Y; Yang L; Hu C; Chen L; Wu S
Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
